We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

Industrial smokestacks emitting thick plumes of smoke into the air at sunset, symbolizing pollution.

Long-Term Exposure to Air Pollution Tied to Brain Tumors

Illustration of a cell's ultrastructure, including the organelles that make up a cell.

Unknown Organelle Discovered Inside Our Cells

Magnifying glass highlighting a yellow capsule among assorted pills, symbolizing gabapentin.

Gabapentin May Raise Dementia Risk – Especially in Middle Age

NIH To Cap Publishing Fees for Federally Funded Research

Gene Editing Unlocks DIY Weight-Loss Drug Delivery

Wearable Wristband Tracks Glucose and Cardiovascular Signals in Real Time

News

Bruker Announces Senior Operations Management Appointment

Appointment of Mr. Stephan Westermann as Executive Vice President.

Bridgehead Completes Due Diligence Assignment for Riverside

Global private equity company secures investment in a fast-growing European pharmaceutical company.

Bridgehead International Provides Due Diligence for Investinor AS

Completion of an $8.8 million Series A financing round.

Vermillion Reports Results for Fourth Quarter and Full Year 2011

Company reports operational and preliminary financial results.

Tecan Award 2011 Winner Announced

Svenja Kristina Holle from UHM has won 2011 award.

Aplastic Anemia Patients in Need of New Treatment Options

New study explores the failings of current treatment options for aplastic anemia.

Agilent to Debut the Agilent Science and Technology Symposium 2012

Symposium combines online and road-show access to experts, technology and science.

Roche and Life Technologies Corporation Sign New PCR IVD Licenses

Companies announced that they have entered into two license agreements to allow LTC to expand its PCR offerings for diagnostics applications.

Estimation of drug-metabolizing capacity by CYP-genotyping and CYP-expression

The lack of therapeutic effect of drugs or the appearance of undesired side-effects is partly caused by differences or changes in drug metabolism. This work aims to introduce an approach of combining CYP-genotyping and CYP-phenotyping tools to estimate patients’ drug-metabolizing capacity.

Launch of DIRECT - An Innovative Medicines Initiative Project for Personalized Medicine in Diabetes

Academia and the pharmaceutical industry working together in the fight against diabetes.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter